Riskpilot← Back to searchSign inGet full accessOPTIKAR NYMARK AS
ASActiveOrg 989145029Almenningen, 6090 FosnavågRetail sale of medical and orthopaedic goods · NACE 4774Est. 20068 employees
Revenue 2024
NOK 5,6M
+3% vs 2023
EBITDA margin
11.1%
-9% vs 2023
Equity ratio
75.1%
Financial strength
Net profit 2024
NOK 288K
-3% vs 2023
| Revenue | NOK 5,6M | +3% |
| EBITDA | NOK 628K | -9% |
| Net profit | NOK 288K | -3% |
| Total assets | NOK 3,5M | +6% |
| Equity | NOK 2,7M | +12% |
| Employees | 8 | — |
Legal name
OPTIKAR NYMARK AS
Org number
989145029
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
5. januar 2006
Share capital
NOK 380 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i felleskap
Company purpose
Sal av kliniske tenester og optiske hjelpemiddel samt andre produkt som naturleg fell saman med dette. Selskapet skal kunne delta i andre verksemder med liknande føremål.
Address
Almenningen, 6090 Fosnavåg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 461 | 5 051 | 4 947 | 5 096 | 5 673 | 5 471 | 5 448 | 6 005 | 5 964 | 5 465 | 5 650 |
| Staff expenses | −1 540 | −1 618 | −1 462 | −1 598 | −1 549 | −1 449 | −1 460 | −1 950 | −1 921 | −1 840 | −1 818 |
| EBITDA | 927 | 668 | 954 | 1 014 | 1 337 | 1 244 | 1 311 | 1 034 | 1 013 | 687 | 628 |
| Depreciation & amort. | −130 | −118 | −108 | −112 | −118 | −190 | −405 | −369 | −368 | −352 | −312 |
| EBIT | 797 | 550 | 846 | 901 | 1 219 | 1 054 | 906 | 665 | 645 | 334 | 316 |
| Net financials | 14 | −6 | −5 | 5 | 10 | 4 | −34 | −20 | 3 | 45 | 57 |
| Profit before tax | 811 | 544 | 841 | 907 | 1 229 | 1 057 | 872 | 644 | 648 | 379 | 373 |
| Tax | 221 | 152 | 213 | 219 | 285 | 233 | 192 | 142 | 145 | 83 | 85 |
| Net profit | 590 | 392 | 628 | 687 | 944 | 825 | 680 | 503 | 503 | 297 | 288 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 932 | 1 918 | 2 572 | 2 502 | 2 793 | 4 273 | 4 304 | 3 607 | 3 363 | 3 343 | 3 541 |
| Equity | 794 | 1 004 | 1 021 | 1 024 | 1 968 | 1 769 | 1 769 | 2 071 | 2 074 | 2 371 | 2 659 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 986 | 871 | 454 | 383 | 312 | 14 |
| Short-term debt | 1 138 | 915 | 1 550 | 1 477 | 825 | 1 519 | 1 664 | 1 082 | 906 | 660 | 868 |
| Total debt | 1 138 | 915 | 1 550 | 1 477 | 825 | 2 505 | 2 535 | 1 536 | 1 288 | 972 | 882 |
EBITDA margin
11.1%
This company
15.8%
Market median
-30% vs market
20142024
Equity ratio
75.1%
This company
38.2%
Market median
+97% vs market
20142024
Return on equity
10.8%
This company
18.4%
Market median
+41% vs market
20142024
Net profit margin
5.1%
This company
8.1%
Market median
-37% vs market
20142024
Asset turnover
1.60×
This company
1.12×
Market median
+43% vs market
20142024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JA Chief Executive Officer | Chief Executive Officer | 2006 | — | — |
HS Deputy Member | Deputy Member | 2006 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2006 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Nymark Invest As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nymark Invest As
OPTIKAR NYMARK AS Board members of OPTIKAR NYMARK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Abraham Nymark | Chief Executive Officer | 0 companies |
| Hans Sivert Nymark | Deputy Member | 0 companies |
| Gitte Nymark | Board of Directors | 0 companies |